Provided herein are oligomeric compounds with conjugate groups. In certain embodiments, the oligomeric compounds are conjugated to N-Acetylgalactosamine.
COMPOSITIONS AND METHODS FOR MODULATING TTR EXPRESSION
申请人:Ionis Pharmaceuticals, Inc.
公开号:US20210024923A1
公开(公告)日:2021-01-28
Provided herein are oligomeric compounds with conjugate groups. In certain embodiments, the oligomeric compounds are conjugated to N-Acetylgalactosamine.